189 related articles for article (PubMed ID: 14505195)
1. Photodynamic therapy with photofrin in combination with Buthionine Sulfoximine (BSO) of human glioma in the nude rat.
Jiang F; Robin AM; Katakowski M; Tong L; Espiritu M; Singh G; Chopp M
Lasers Med Sci; 2003; 18(3):128-33. PubMed ID: 14505195
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy with photofrin reduces invasiveness of malignant human glioma cells.
Jiang F; Chopp M; Katakowski M; Cho KK; Yang X; Hochbaum N; Tong L; Mikkelsen T
Lasers Med Sci; 2002; 17(4):280-8. PubMed ID: 12417983
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy using Photofrin in combination with buthionine sulfoximine (BSO) to treat 9L gliosarcoma in rat brain.
Jiang F; Lilge L; Belcuig M; Singh G; Grenier J; Li Y; Chopp M
Lasers Surg Med; 1998; 23(3):161-6. PubMed ID: 9779650
[TBL] [Abstract][Full Text] [Related]
4. The effect of photodynamic therapy on a retinoblastoma-like tumour. An experimental in vitro and in vivo study on the potential use of photodynamic therapy in the treatment of retinoblastoma.
Winther JB
Acta Ophthalmol Suppl (1985); 1990; (197):1-37. PubMed ID: 2176429
[TBL] [Abstract][Full Text] [Related]
5. Subclinical photodynamic therapy treatment modifies the brain microenvironment and promotes glioma growth.
deCarvalho AC; Zhang X; Roberts C; Jiang F; Kalkanis SN; Hong X; Lu M; Chopp M
Glia; 2007 Aug; 55(10):1053-60. PubMed ID: 17551928
[TBL] [Abstract][Full Text] [Related]
6. The influence of cellular glutathione content on cell survival following photodynamic treatment in vitro.
Miller AC; Henderson BW
Radiat Res; 1986 Jul; 107(1):83-94. PubMed ID: 2942963
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo photosensitizing applications of Photofrin in malignant melanoma cells.
Chang CJ; Yu JS; Wei FC
Chang Gung Med J; 2008; 31(3):260-7. PubMed ID: 18782948
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin reduces functional deficits caused by photodynamic therapy in rats.
Zheng X; Chopp M; Lu Y; Jiang J; Zhao D; Ding C; Yang H; Zhang L; Jiang F
Int J Oncol; 2011 Nov; 39(5):1133-41. PubMed ID: 21850369
[TBL] [Abstract][Full Text] [Related]
9. Combination of surgical resection and photodynamic therapy of 9L gliosarcoma in the nude rat.
Zhang X; Jiang F; Kalkanis SN; Yang H; Zhang Z; Katakowski M; Hong X; Zheng X; Chopp M
Photochem Photobiol; 2006; 82(6):1704-11. PubMed ID: 17007560
[TBL] [Abstract][Full Text] [Related]
10. Synergistic cytotoxicity of buthionine sulfoximine (BSO) and intensive melphalan (L-PAM) for neuroblastoma cell lines established at relapse after myeloablative therapy.
Anderson CP; Reynolds CP
Bone Marrow Transplant; 2002 Aug; 30(3):135-40. PubMed ID: 12189530
[TBL] [Abstract][Full Text] [Related]
11. Role of mitochondria in cell death induced by Photofrin-PDT and ursodeoxycholic acid by means of SLIM.
Kinzler I; Haseroth E; Hauser C; Rück A
Photochem Photobiol Sci; 2007 Dec; 6(12):1332-40. PubMed ID: 18046490
[TBL] [Abstract][Full Text] [Related]
12. A multispectral fluorescence imaging system: design and initial clinical tests in intra-operative Photofrin-photodynamic therapy of brain tumors.
Yang VX; Muller PJ; Herman P; Wilson BC
Lasers Surg Med; 2003; 32(3):224-32. PubMed ID: 12605430
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine.
Wu XX; Ogawa O; Kakehi Y
Int J Oncol; 2004 Jun; 24(6):1489-97. PubMed ID: 15138592
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effect of photodynamic therapy in mice using direct application of Photofrin dissolved in lidocaine jelly.
Murakami H; Kohno E; Kohmura Y; Ozawa H; Ito H; Sugihara K; Horiuchi K; Hirano T; Kanayama N
Photodermatol Photoimmunol Photomed; 2009 Oct; 25(5):259-63. PubMed ID: 19747245
[TBL] [Abstract][Full Text] [Related]
15. Pc 4 photodynamic therapy of U87-derived human glioma in the nude rat.
George JE; Ahmad Y; Varghai D; Li X; Berlin J; Jackowe D; Jungermann M; Wolfe MS; Lilge L; Totonchi A; Morris RL; Peterson A; Lust WD; Kenney ME; Hoppel CL; Sun J; Oleinick NL; Dean D
Lasers Surg Med; 2005 Jun; 36(5):383-9. PubMed ID: 15965990
[TBL] [Abstract][Full Text] [Related]
16. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy of human glioma (U87) in the nude rat.
Chopp M; Madigan L; Dereski M; Jiang F; Li Y
Photochem Photobiol; 1996 Oct; 64(4):707-11. PubMed ID: 8863478
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy of U87 human glioma in nude rat using liposome-delivered photofrin.
Jiang F; Lilge L; Grenier J; Li Y; Wilson MD; Chopp M
Lasers Surg Med; 1998; 22(2):74-80. PubMed ID: 9484699
[TBL] [Abstract][Full Text] [Related]
19. Effects of ALA-mediated photodynamic therapy on the invasiveness of human glioma cells.
Hirschberg H; Sun CH; Krasieva T; Madsen SJ
Lasers Surg Med; 2006 Dec; 38(10):939-45. PubMed ID: 17163479
[TBL] [Abstract][Full Text] [Related]
20. In vitro survival of nonsmall cell lung cancer cells following combined treatment with ionizing radiation and photofrin-mediated photodynamic therapy.
Sharma P; Farrell T; Patterson MS; Singh G; Wright JR; Sur R; Rainbow AJ
Photochem Photobiol; 2009; 85(1):99-106. PubMed ID: 18643904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
